Study of AZD5863 in Adult Participants with Advanced or Metastatic Solid Tumors

Trial Identifier: D9750C00001
Sponsor: AstraZeneca
Start Date: July 2023
Primary Completion Date: June 2027
Study Completion Date: June 2027
Condition: Gastric Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CN Beijing, CN, 100142
CN Beijing, CN, 101199
CN Shandong, CN
FR Toulouse, FR, 31059
FR Villejuif Cedex, FR, 94805
GB Dundee, GB, DD1 9SY
GB London, GB, E1 1BB
GB Oxford, GB, OX3 7LE
GB Wirral, GB, CH63 4JY
JP Chuo-ku, JP, 104-0045
JP Kashiwa, JP, 227-8577
JP Koto-ku, JP, 135-8550
KR seoul, KR, 06351
KR Seoul, KR, 03080
KR Seoul, KR, 05505
KR Seoul, KR, 03722
NL Amsterdam, NL, 1081 HV
NL Groningen, NL, 9713 GZ
NL ROTTERDAM, NL, 3015 GD
TW Kaohsiung, TW, 80756
TW Tainan City, TW, 70403
TW Taoyuan, TW, 00333
US, FL Jacksonville, FL, US, 32224
US, MN Rochester, MN, US, 55905